- Home
- MEGL vs BCLI Comparison
MEGL vs BCLI Comparison
Compare MEGL & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEGL
- BCLI
- Stock Information
- Founded
- MEGL 2016
- BCLI 2000
- Country
- MEGL Hong Kong
- BCLI United States
- Employees
- MEGL N/A
- BCLI N/A
- Industry
- MEGL Finance: Consumer Services
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MEGL Finance
- BCLI Health Care
- Exchange
- MEGL Nasdaq
- BCLI Nasdaq
- Market Cap
- MEGL 9.0M
- BCLI 9.9M
- IPO Year
- MEGL 2022
- BCLI N/A
- Fundamental
- Price
- MEGL $1.42
- BCLI $1.19
- Analyst Decision
- MEGL
- BCLI Strong Buy
- Analyst Count
- MEGL 0
- BCLI 1
- Target Price
- MEGL N/A
- BCLI $30.00
- AVG Volume (30 Days)
- MEGL 32.5K
- BCLI 35.3K
- Earning Date
- MEGL 04-21-2025
- BCLI 03-31-2025
- Dividend Yield
- MEGL N/A
- BCLI N/A
- EPS Growth
- MEGL N/A
- BCLI N/A
- EPS
- MEGL N/A
- BCLI N/A
- Revenue
- MEGL $1,976,138.00
- BCLI N/A
- Revenue This Year
- MEGL N/A
- BCLI $170.09
- Revenue Next Year
- MEGL N/A
- BCLI N/A
- P/E Ratio
- MEGL N/A
- BCLI N/A
- Revenue Growth
- MEGL 67.75
- BCLI N/A
- 52 Week Low
- MEGL $0.41
- BCLI $1.05
- 52 Week High
- MEGL $3.06
- BCLI $11.25
- Technical
- Relative Strength Index (RSI)
- MEGL 52.99
- BCLI 29.41
- Support Level
- MEGL $1.38
- BCLI $1.15
- Resistance Level
- MEGL $1.55
- BCLI $1.28
- Average True Range (ATR)
- MEGL 0.11
- BCLI 0.12
- MACD
- MEGL -0.02
- BCLI -0.02
- Stochastic Oscillator
- MEGL 25.00
- BCLI 11.54
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.